宏源药业：公司重视六氟磷酸锂业务的发展
Hubei Hongyuan Pharmaceutical Technology Hubei Hongyuan Pharmaceutical Technology (SZ:301246) Zheng Quan Ri Bao Wang·2025-10-31 09:45

Group 1 - The company emphasizes the importance of developing its lithium hexafluorophosphate business [1] - The company plans to enhance its competitiveness in the lithium hexafluorophosphate sector through technological upgrades and extending upstream in the supply chain [1]